Thus, given the fact that LVH is strongly linked to increased risk of heart failure in clinical studies [42], targeting ET-1 signaling pathway and LVH may help minimize the susceptibility of patients with breast cancer to cardiovascular disease and ultimately improve their survival. The gene discussed is EDN1; the disease is heart failure.